Markwell Clarizio LLP

Menu
Contact Us

Federal Court Grants an Application to Add Inventors and an Owner to an Issued Patent

IP Decisions /

 On May 31, 2024, the Federal Court (Tsimberis J.) granted an application to correct the inventorship of an issued patent. The decision provides a clear explanation of the relevant legal principles (Patent Act, s. 52) and the type of evidence that must be led to obtain relief. Smith Sport Optics, Inc. v. Canada (Commissioner of […]

Federal Court Grants an Application to Add Inventors and an Owner to an Issued Patent Read More »

Court Dismisses Passing Off and Expungement Action After Summary Trial

IP Decisions /

This was a motion for summary trial in a passing off and expungement case between competitors in the mobile video game market. The Court (per Fuhrer J.) held that summary trial was an appropriate vehicle for deciding the Plaintiff’s claims for passing off and expungement of the Defendant’s registration – and that those claims were

Court Dismisses Passing Off and Expungement Action After Summary Trial Read More »

Federal Court Re-Iterates that the Fair Dealing Exception to Copyright Infringement is Fact Specific

IP Decisions /

On May 31, 2024, the Federal Court (Roy J) released its decision on the summary judgment motion brought by the Attorney General of Canada (“AGC”) on behalf of Parks Canada, in which he dismissed Blacklock’s Reporter’s (“BR”) copyright infringement action against the AGC. This matter is one of several related and contextually similar actions brought

Federal Court Re-Iterates that the Fair Dealing Exception to Copyright Infringement is Fact Specific Read More »

Red Maple Manufacturing Inc. v. Red Maple Bio Inc. 2024 FC 817

IP Decisions /

On May 29, 2024, the Federal Court (Whyte Nowak J.) granted Red Maple Manufacturing Inc.’s (the “Applicant”) appeal pursuant to subsection 56(1) of the Trademarks Act. The Applicant appealed a decision from the Trademarks Opposition Board (“the Board”) ordering the removal of certain goods from the Applicant’s Trademark Registration. Red Maple Manufacturing Inc. v. Red

Red Maple Manufacturing Inc. v. Red Maple Bio Inc. 2024 FC 817 Read More »

Parliamentary Committee Issues Report on PMPRB Reform. Calls for “Comprehensive Response” by the Government

IP Decisions /

Parliamentary Committee Issues Report on PMPRB Reform. Calls for “Comprehensive Response” by the Government On May 6, 2024, Canada’s Standing Committee on Health (“HESA”) issued a report containing “ten recommendations on how the Government of Canada can enable the Patented Medicine Prices Review Board (“PMPRB”) to more effectively carry out its mandate and implement its

Parliamentary Committee Issues Report on PMPRB Reform. Calls for “Comprehensive Response” by the Government Read More »

Markwell Clarizio LLP is a Contributor to the Chambers Life Sciences 2024 Global Practice Guide

Announcements /

Chambers and Partners has recently published its 2024 Life Sciences Global Practice Guide. Markwell Clarizio LLP is very pleased to have been invited to be the exclusive author of the Canadian sections of this comprehensive practice guide which is considered the “definitive global law guide offering comparative analysis from top ranked lawyers”. In the Canadian

Markwell Clarizio LLP is a Contributor to the Chambers Life Sciences 2024 Global Practice Guide Read More »

Federal Court of Appeal Interprets “Use” in Section 42 of the Patent Act

IP Decisions /

The Federal Court of Appeal (per Heckman J.A.) dismissed an appeal by Steelhead LNG (ASLNG) Ltd. and Steelhead LNG Limited Partnership (collectively, “Steelhead”) from a summary trial judgment dismissing Steelhead’s patent infringement action. This appeal turned on the meaning of “use” under section 42 of the Patent Act. Steelhead LNG (ASLNG) Ltd v Arc Resources

Federal Court of Appeal Interprets “Use” in Section 42 of the Patent Act Read More »

Federal Court of Appeal Confirms That Cialis Patent is Invalid

IP Decisions /

The Federal Court of Appeal (per Locke JA.) affirmed a trial decision in which claims in Lilly’s patent covering physiologically acceptable salts of tadalafil were found to be invalid for overbreadth and insufficiency. The principal issue on appeal was the proper construction of the claim term “physiologically acceptable”, though the Court’s obiter statements regarding the

Federal Court of Appeal Confirms That Cialis Patent is Invalid Read More »

Federal Court Finds Flaws in Online Survey Evidence and Reminds About Descriptive Certification Marks

IP Decisions /

The Federal Court (Tsimberis J.) dismissed an appeal by Promotion in Motion, Inc. (“PIM”) from a Trademark Opposition Board (“Board”) decision refusing PIM’s applications to register its SWISSKISS mark and SWISSKISS & Design mark in association with “chocolate of Swiss origin”. Hershey Chocolate & Confectionary LLC (“Hershey”) successfully opposed PIM’s applications based on Hershey’s registered

Federal Court Finds Flaws in Online Survey Evidence and Reminds About Descriptive Certification Marks Read More »

Federal Court Determines Admissibility of Testimony from Fact Witnesses who Authored Prior Art

IP Decisions /

In Medexus Pharmaceuticals v Accord Healthcare (2024 FC 424), Justice Pallotta dismissed the plaintiffs’ (“Medexus”) patent infringement action after finding that the patent at issue (“662 Patent”) was invalid for obviousness. The 662 Patent related to concentrations of subcutaneously injected methotrexate solutions used to treat rheumatoid arthritis and psoriasis/psoriatic arthritis. The decision addresses an interesting

Federal Court Determines Admissibility of Testimony from Fact Witnesses who Authored Prior Art Read More »